TCR2 Therapeutics Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.31
Target price
04.02.24
€3.00
Performance (%)
34.48%
End price
05.05.23
€1.76
Summary
This prediction ended on 05.05.23 with a price of €1.76. The BUY prediction by BiotechBee for TCR2 Therapeutics Inc. saw massive gains of 34.48%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year